These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15666177)

  • 1. Comparison of D&C and hysterectomy pathologic findings in endometrial cancer patients.
    Wang X; Huang Z; Di W; Lin Q
    Arch Gynecol Obstet; 2005 Jul; 272(2):136-41. PubMed ID: 15666177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of preoperative curettage in determining tumor type and grade in endometrial cancer.
    Thanachaiviwat A; Thirapakawong C; Leelaphatanadit C; Chuangsuwanich T
    J Med Assoc Thai; 2011 Jul; 94(7):766-71. PubMed ID: 21774280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
    Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
    Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical factors affecting the diagnostic accuracy of assessing dilation and curettage vs frozen section specimens for histologic grade and depth of myometrial invasion in endometrial carcinoma.
    Wang X; Zhang H; Di W; Li W
    Am J Obstet Gynecol; 2009 Aug; 201(2):194.e1-194.e10. PubMed ID: 19564019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma.
    Oreskovic S; Babic D; Kalafatic D; Barisic D; Beketic-Oreskovic L
    Gynecol Oncol; 2004 Apr; 93(1):34-40. PubMed ID: 15047211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma.
    Leitao MM; Kehoe S; Barakat RR; Alektiar K; Gattoc LP; Rabbitt C; Chi DS; Soslow RA; Abu-Rustum NR
    Gynecol Oncol; 2009 Apr; 113(1):105-8. PubMed ID: 19167049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer.
    Larson DM; Johnson KK; Broste SK; Krawisz BR; Kresl JJ
    Obstet Gynecol; 1995 Jul; 86(1):38-42. PubMed ID: 7784020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferating cell nuclear antigen in endometrial carcinoma: pretreatment identification of high-risk patients.
    Garzetti GG; Ciavattini A; Goteri G; De Nictolis M; Romanini C
    Gynecol Oncol; 1996 Apr; 61(1):16-21. PubMed ID: 8626110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. bcl-2 and p53 in endometrial adenocarcinoma.
    Taskin M; Lallas TA; Barber HR; Shevchuk MM
    Mod Pathol; 1997 Jul; 10(7):728-34. PubMed ID: 9237185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
    Ferrandina G; Ranelletti FO; Gallotta V; Martinelli E; Zannoni GF; Gessi M; Scambia G
    Gynecol Oncol; 2005 Sep; 98(3):383-9. PubMed ID: 15979129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
    Kounelis S; Kapranos N; Kouri E; Coppola D; Papadaki H; Jones MW
    Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of bcl-2 in endometrioid corpus cancer: an experimental study.
    Mariani A; Sebo TJ; Cliby WA; Keeney GL; Riehle DL; Lesnick TG; Podratz KC
    Anticancer Res; 2006; 26(2A):823-7. PubMed ID: 16619475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
    Ma XX; Zhang SL; Gao S; Lu JM; Dong F
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic markers for coexistent carcinoma in high-risk endometrial hyperplasia with negative D-score: significance of morphometry, hormone receptors and apoptosis for outcome prediction.
    Ørbo A; Kaino T; Arnes M; Larsen K; Pettersen I; Moe B
    Acta Obstet Gynecol Scand; 2009; 88(11):1234-42. PubMed ID: 19900140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
    Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 and p53 expression in stage I endometrial carcinoma.
    Giatromanolaki A; Sivridis E; Koukourakis MI; Harris AL; Gatter KC
    Anticancer Res; 1998; 18(5B):3689-93. PubMed ID: 9854478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the time interval between hysteroscopy, dilation and curettage, and hysterectomy on survival in patients with endometrial cancer.
    Hefler L; Leipold H; Hinterberger S; Concin N; Klotz R; Reinthaller A
    Obstet Gynecol; 2008 Nov; 112(5):1098-101. PubMed ID: 18978111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of p53 protein in women with endometrial cancer].
    Ivanov S; Khadzhiolov N; Ivanov S
    Akush Ginekol (Sofiia); 2001; 40(4):14-5. PubMed ID: 11803862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.